Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, OpGen (OPGN) has a market cap of $12.082 million USD. According to our data, OpGen is ranked No.8799 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $12.08 M |
101.68%
|
| Dec 31, 2024 | $5.99 M |
-85.83%
|
| Dec 29, 2023 | $42.29 M |
-85.11%
|
| Dec 30, 2022 | $0.28 B |
-85.90%
|
| Dec 31, 2021 | $2.01 B |
-50.98%
|
| Dec 31, 2020 | $4.11 B |
80.53%
|
| Dec 31, 2019 | $2.28 B |
-95.65%
|
| Dec 31, 2018 | $52.35 B |
-72.19%
|
| Dec 29, 2017 | $188.27 B |
-83.74%
|
| Dec 30, 2016 | $1.158 T |
-39.47%
|
| Dec 31, 2015 | $1.913 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Becton Dickinson
BDX
|
$69.00 B |
-0.002 M
|
USA
|
 Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
 Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
 Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
 Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
 Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
 Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
 Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
 Bruker
BRKR
|
$9.11 B |
0.000 M
|
USA
|
 QuidelOrtho
QDEL
|
$2.99 B |
-0.000 M
|
USA
|
 Accelerate Diagnostics
AXDX
|
$28.05 M |
0.000 M
|
USA
|
| Market Cap | = | OPGN Stock Price | * | OPGN Shares Outstanding |
| = | $1.20 | * | 10.07 M | |
| = | $12.08 M |